Peter Vedsted

Position paper: Breast cancer screening, diagnosis, and treatment in Denmark

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Position paper : Breast cancer screening, diagnosis, and treatment in Denmark. / Christiansen, Peer; Vejborg, Ilse Merete Munk; Kroman, Niels Thorndahl; Holten, Iben Wulff; Garne, Jens Peter; Vedsted, Peter; Møller, Susanne; Lynge, Elsebeth.

I: Acta oncologica (Stockholm, Sweden), 05.02.2014.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Christiansen, P, Vejborg, IMM, Kroman, NT, Holten, IW, Garne, JP, Vedsted, P, Møller, S & Lynge, E 2014, 'Position paper: Breast cancer screening, diagnosis, and treatment in Denmark', Acta oncologica (Stockholm, Sweden). https://doi.org/10.3109/0284186X.2013.874573

APA

Christiansen, P., Vejborg, I. M. M., Kroman, N. T., Holten, I. W., Garne, J. P., Vedsted, P., ... Lynge, E. (2014). Position paper: Breast cancer screening, diagnosis, and treatment in Denmark. Acta oncologica (Stockholm, Sweden). https://doi.org/10.3109/0284186X.2013.874573

CBE

MLA

Vancouver

Christiansen P, Vejborg IMM, Kroman NT, Holten IW, Garne JP, Vedsted P o.a. Position paper: Breast cancer screening, diagnosis, and treatment in Denmark. Acta oncologica (Stockholm, Sweden). 2014 feb 5. https://doi.org/10.3109/0284186X.2013.874573

Author

Christiansen, Peer ; Vejborg, Ilse Merete Munk ; Kroman, Niels Thorndahl ; Holten, Iben Wulff ; Garne, Jens Peter ; Vedsted, Peter ; Møller, Susanne ; Lynge, Elsebeth. / Position paper : Breast cancer screening, diagnosis, and treatment in Denmark. I: Acta oncologica (Stockholm, Sweden). 2014.

Bibtex

@article{3bbab38bf5ff46e392401c5e51549191,
title = "Position paper: Breast cancer screening, diagnosis, and treatment in Denmark",
abstract = "Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20{\%} of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010. Material and methods. Based on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included. Results and conclusion. Using incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25{\%} in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4{\%}. Others have estimated overdiagnosis to be 33{\%}. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3{\%} per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25{\%} to 69{\%} in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased.",
author = "Peer Christiansen and Vejborg, {Ilse Merete Munk} and Kroman, {Niels Thorndahl} and Holten, {Iben Wulff} and Garne, {Jens Peter} and Peter Vedsted and Susanne M{\o}ller and Elsebeth Lynge",
year = "2014",
month = "2",
day = "5",
doi = "10.3109/0284186X.2013.874573",
language = "English",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Taylor & francis",

}

RIS

TY - JOUR

T1 - Position paper

T2 - Breast cancer screening, diagnosis, and treatment in Denmark

AU - Christiansen, Peer

AU - Vejborg, Ilse Merete Munk

AU - Kroman, Niels Thorndahl

AU - Holten, Iben Wulff

AU - Garne, Jens Peter

AU - Vedsted, Peter

AU - Møller, Susanne

AU - Lynge, Elsebeth

PY - 2014/2/5

Y1 - 2014/2/5

N2 - Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010. Material and methods. Based on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included. Results and conclusion. Using incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25% in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4%. Others have estimated overdiagnosis to be 33%. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3% per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25% to 69% in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased.

AB - Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010. Material and methods. Based on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included. Results and conclusion. Using incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25% in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4%. Others have estimated overdiagnosis to be 33%. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3% per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25% to 69% in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased.

U2 - 10.3109/0284186X.2013.874573

DO - 10.3109/0284186X.2013.874573

M3 - Journal article

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

ER -